Perspective 37Safety & Emergency · Health & Care

Patients Should Not Have to Be Medicine Detectives

A medicine is trust in a small strip, bottle or box. Some are falsified, some fail quality tests, and some are recalled without the patient ever knowing.

The strip in the kitchen cupboard

The story below is illustrative. It is not about a real person.

A man buys his father's blood pressure medicine from the same pharmacy every month. One month, the strip looks slightly different. He scans the QR code, and a page loads with technical details he cannot interpret.

Two months later, a newspaper reports that a batch of that medicine failed quality tests. He has no way to know whether his father's strips were from that batch. The pharmacist does not know either.

Thousands of failed samples a year

According to a written reply by the Union Health Minister to the Lok Sabha, reported by PTI in December 2025, about 1.16 lakh drug samples were tested in 2024-25. 3,104 were declared not of standard quality and 245 spurious or adulterated. In 2023-24, of about 1.06 lakh samples, 2,988 were not of standard quality and 282 spurious or adulterated.

Most medicines in India are safe. The problem is that patients cannot tell which ones are not.

More is in place than most patients know

  • Monthly drug alerts. CDSCO and state regulators publish lists of drug samples that fail tests.
  • QR codes. Required on many active pharmaceutical ingredients and on top-selling drug brands.
  • Risk-based inspections of manufacturing sites by central and state regulators.
  • Pharmacovigilance. The Pharmacovigilance Programme of India collects reports of adverse drug reactions.

Where trust breaks

  • Alerts do not reach patients. They are published as technical lists.
  • QR results are unreadable. A code that shows data, but not "safe" or "not safe", does not build trust.
  • Recalls stop at the warehouse. Patients who have already bought a failed batch are not told.
  • Pharmacies cannot trace batches to the patients they sold them to.
  • Lab confirmation is slow, so suspect medicines stay on shelves.

The redesign: a Medicine Trust OS

A design to test. Not a claim of achieved outcomes.

  1. A clear verify-before-you-buy check.

    Scan or type a code and get a simple answer: genuine, recalled or unknown.

  2. Plain-language QR results, in Indian languages, with what to do next.

  3. Recall alerts that reach the patient, through pharmacies, e-pharmacies and prescription records.

  4. Pharmacy-level traceability.

    Batches recorded at sale, so recalls can be targeted.

  5. Fast lab confirmation when a pharmacist or patient reports a suspect product.

Where AI helps, and where regulators decide

AI can flag suspicious patterns in drug alerts, complaints and sales data, and help target inspections.

Regulators and accredited labs make the final call on quality. Patients should always check with a pharmacist or doctor before stopping a medicine.

Start with one state

One state drug controller can pilot plain-language QR checks, batch tracking at pharmacies and patient recall alerts for high-use medicines for a year. Our planning estimate is ₹1 to 1.5 crore.

The measures that matter are patients reached by recall alerts, time from failed test to removal from shelves, and verification checks used by buyers.

What each of us can do

Who can act and the next step
Patientsbuy from licensed pharmacies, keep your bill and ask your pharmacist about any medicine that looks different.
Pharmacies and e-pharmaciesrecord batch numbers at sale.
CDSCO and state drug controllerspublish alerts in plain language and push them to pharmacies.
Manufacturersmake QR results simple and meaningful.
Testing labsoffer fast checks on suspect samples.

Trust that can be verified

Patients should not have to become medicine detectives. When every strip can be checked in seconds, and every recall reaches the person who bought it, trust becomes something the system earns.

Watch the full episode →

Redesigning Medicine Safety in India: The Fake Medicine Trust Gap

Your turn: do you check a medicine's QR code before buying? What would make you trust the result? Tell us in the comments on the video, and subscribe to Better India By Design for the next redesign.

Watch on YouTube →

Sources and notes

Figures reflect the periods, populations and definitions in the cited material. They are not live totals.

  1. 01
    The Week (PTI), "Over 3,000 drug samples declared not of standard quality in 2024-25: Nadda", December 2025. Link

This article is for public information and is not medical advice. Do not stop any medicine without talking to your doctor or pharmacist.

Pilot costs are Better India By Design planning estimates, not government figures.

Researched with AI assistance. Facts checked against the cited sources and reviewed by the BIBD Editorial Team.

BIBD proposals are designs to test, not claims of achieved outcomes. Pilot costs are planning estimates unless a source states otherwise.

Website edition prepared from the supplied Perspective on 31 October 2026. Original document →

Continue reading

Another system. A connected question.